Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 413-420

  Yin, F ^a   Giuliano, A E ^a   Law, R E ^a   Van Herle, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apigenin; Breast cancer cell; CDKs; Cyclins; ERK MAP kinase; G2 M arrest; Growth inhibition; pRb

Indexed keywords

APIGENIN; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; REGULATOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTER; GROWTH INHIBITION; HUMAN; HUMAN CELL; MODULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APIGENIN; BREAST NEOPLASMS; CARCINOMA; CDC2 PROTEIN KINASE; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; FLAVONOIDS; G2 PHASE; HUMANS; KINETICS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MITOSIS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0035059767     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cancer statistics
2. Cancer statistics
3. Soy intake and cancer risk: A review of the in vitro and in vivo data
4. Dietary effects on breast-cancer risk in Singapore
5. Dietary phytoestrogens and cancer: In vitro and in vivo studies
6. The role of soy products in reducing risk of cancer
7. Growth inhibitory effect of flavonoids in human thyroid cancer cell lines
8. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells
9. Expression of cell cycle- dependent genes in young and senescent WI-38 fibroblasts
10. G1 phaseprogression: Cyclingoncue
11. Mammalian G1 cyclins
12. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
13. Cancer cell cycles
14. Cell cycle control in normal and neoplastic cells
15. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
16. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development
17. A cell cycle regulator potentially involved in genesis of many tumor types
18. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
19. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase
20. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast
21. Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells
22. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
23. Phosphorylation of cjun mediated by MAP kinases
24. MAPKs: New JNK expands the group
25. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling
26. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
27. Assembly of cyclin D-dependent kinase and titration of p27Kipl regulated by mitogen-activated protein kinase kinase (MEK1)
28. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells
29. Transformation of mammalian cells by constitutively active MAP kinase kinase
30. Altered MAP kinase (ERK1, 2) regulation in primary cultures of mammary tumor cells: Elevated basal activity and sustained response to EGF
31. The retinoblastoma protein and cell cycle control
32. Hypophosphorylation of the RB protein in S and G2 as well as G1 during growth arrest
33. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
34. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
35. Cdk inhibitors: On the threshold of checkpoints and development
36. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
37. Principles of CDK regulation
38. A cyclin D-Cdk4 activity required for G2 phase cell cycle progression is inhibited in ultraviolet radiation-induced G2 phase delay
39. Expression and amplification of cyclin genes in human breast cancer
40. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2
41. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase
42. Inhibition of cyclin-dependent kinases by purine analogues
43. Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases
44. Effects of p21 (Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
45. RB kinases and RB-binding proteins: New points of view
46. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
47. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts
48. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
49. Mitogen-activated protein kinase kinase activity is required for the G (2)/M transition of the cell cycle in mammalian fibroblasts
50. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
51. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity
52. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells
53. Mitogen-activated protein kinase activation down- regulates a mechanism that inactivates cyclin B-cdc2 kinase in G2-arrested oocytes